BIO-key International (NASDAQ:BKYI) Stock Price Crosses Below 200-Day Moving Average – Here’s Why

BIO-key International Inc. (NASDAQ:BKYI)’s share price passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $4.90 and traded as low as $2.93. BIO-key International shares last traded at $2.93, with a volume of 6,369 shares changing hands.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on BKYI shares. Weiss Ratings restated a “sell (e+)” rating on shares of BIO-key International in a research note on Friday, July 17th. Zacks Research upgraded shares of BIO-key International to a “hold” rating in a research note on Thursday, August 6th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Reduce”.

BIO-key International Price Performance

The firm has a 50-day simple moving average of $4.03 and a 200-day simple moving average of $4.88. The firm has a market capitalization of $4.02 million, a PE ratio of -0.68 and a beta of 0.40.

BIO-key International (NASDAQ:BKYI) last posted its quarterly earnings data on Thursday, August 13th. The technology company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.82) by $0.26. The firm had revenue of $1.92 million during the quarter, compared to analyst estimates of $1.80 million. BIO-key International had a negative return on equity of 67.31% and a negative net margin of 50.01%. Equities analysts expect that BIO-key International Inc. will post -1.62 earnings per share for the current year.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC raised its holdings in shares of BIO-key International Inc. (NASDAQ:BKYI) by 49.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 48,892 shares of the technology company’s stock after acquiring an additional 16,271 shares during the quarter. Geode Capital Management LLC owned approximately 0.45% of BIO-key International worth $26,000 as of its most recent SEC filing. Institutional investors and hedge funds own 26.51% of the company’s stock.

BIO-key International Company Profile

BIO-key International, Inc is a developer and provider of fingerprint biometric identity and access management solutions, serving enterprise and government customers. The company’s core offerings include a range of fingerprint readers and authentication software designed to verify user identity across physical and digital environments. By leveraging proprietary template-on-card and template-on-device technologies, BIO-key seeks to enhance security and streamline user access without reliance on traditional passwords.

In addition to hardware sensors, BIO-key delivers software platforms that integrate with existing IT infrastructures such as Microsoft Active Directory and major workforce management systems.